245
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Preparation, optimization, and evaluation of Zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery

, &
Pages 297-306 | Received 17 May 2015, Accepted 12 Nov 2015, Published online: 19 Jan 2016

References

  • Attwood D. (1994) Microemulsions. In: Kreuter J, ed. Colloidal drug delivery systems. New York: Marcel Dekker, 31–71
  • Badran MM, Kuntsche J, Fahr A. (2009). Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci 36:511–23
  • Baek JS, Lim JH, Kang JS, et al. (2013). Enhanced transdermal drug delivery of zaltoprofen using a novel formulation. Int J Pharm 453:358–62
  • Baker AK, Hoffmann VLH, Meert TF. (2002). Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Pharmacol Biochem Behav 74:73–86
  • Bang JS, Oh DH, Choi HM, et al. (2009). Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 11:R49
  • Bolzinger MA, Brianc S, Pelletier J, et al. (2008). Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. Eur J Pharm Biopharm 68:446–51
  • Chatterjee A, Varshney MS, Himanshu M, et al. (2014). Formulation and in-vitro characterization of zaltoprofen transdermal patch using different polymers. Int J Pharm Sci Rev Res 27:277
  • Chen H, Chang X, Du D, et al. (2006). Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharm 315:52–8
  • Farshid AB, Tamaddonfard E, Yahyaee F. (2010). Effects of histidine and N-acetylcysteine on diclofenac-induced anti-inflammatory response in acute inflammation in rats. Ind J Exp Biol 48:1136–42
  • Gomaa YA, El-Khordagui LK, Garland MJ, et al. (2012). Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye. J Pharm Pharmacol 64:1592–602
  • Hathout RM, Elshafeey AH. (2012). Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker. Eur J Pharm Biopharm 82:230–40
  • Hunter RJ. (1981). Zeta potential in colloid science. New York: Academic Press
  • Kawai S. (1998). Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration. Inflamm Res 47:102–6
  • Khurana S, Jain NK, Bedi PM. (2013). Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci 92:383–92
  • Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
  • Li L, Ma P, Cao Y, et al. (2011). Single-dose and multiple dose pharmacokinetics of zaltoprofen after oral administration in healthy Chinese volunteers. J Biomed Res 25:56–62
  • Malakar J, Nayak AK, Basu A. (2012). Ondansetron HCl microemulsions for transdermal delivery: formulation and in vitro skin permeation. ISRN Pharm 2012:428396
  • Matsumoto M, Inoue M, Ueda H. (2006). NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings. Neurosci Lett 397:249–53
  • Mutimer MN, Riffkin C, Hill JA, et al. (1956). Modern ointment bases technology–II – comparative evaluation of bases. J Am Pharm Assoc 15:212–18
  • Ogiso T, Niinaka N, Iwaki M. (1996). Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci 85:57–64
  • Polizelli MA, Telis VRN, Amaral LQ, Feitosa E. (2006). Formation and characterization of soy bean oil/surfactant/water microemulsions. Colloids Surf A 281:230–6
  • Ricciotti E, FitzGerald GA. (2011). Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986–1000
  • Senye M, Mir CF, Morton S, Thie NM. (2012). Topical nonsteroidal anti-inflammatory medications for treatment of temporomandibular joint degenerative pain: a systematic review. J Orofac Pain 26:26–32
  • Tsurumi K, Kyuki K, Niwa M, et al. (1986). Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b, f]thiepin-2-yl)propionic acid. 1st communication: inhibitory effects of rat paw edema. Arzneimittelforschung 36:1796–800
  • Winter CA, Risley EA, Nuss CW. (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111:544–7
  • Wood JH, Catacalos G, Lieberman SV. (1963). Adaptation of commercial viscometers for special applications in pharmaceutical rheology. II. Severs extrusion rheometer. J Pharm Sci 52:375–8
  • Yue Y, San-Ming L, Pan D, Da-Fang Z. (2007). Physicochemical properties and evaluation of microemulsion systems for transdermal delivery of meloxicam. Chem Res Chin Univ 23:81–6
  • Zarghi A, Arfaei S. (2011). Selective COX-2 inhibitors: a review of their structure-activity relationships. Iran J Pharm Res 10:655–83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.